Lipa Pharmaceuticals Limited

[2019] FWCA 6140

[2019] FWCA 6140

FAIR WORK COMMISSION

DECISION

Fair Work Act 2009
s.185—Enterprise agreement

Lipa Pharmaceuticals Limited
(AG2019/2521)

LIPA PHARMACEUTICALS LTD - EMPLOYEE COLLECTIVE AGREEMENT 2018 - 2020

Pharmaceutical industry
COMMISSIONER WILSON	MELBOURNE, 3 SEPTEMBER 2019

Application for approval of the Lipa Pharmaceuticals Ltd - Employee Collective Agreement 2018-2020.

[1] An application has been made for approval of an enterprise agreement known as the Lipa Pharmaceuticals Ltd - Employee Collective Agreement 2018-2020 (the Agreement). The application was made pursuant to s.185 of the Fair Work Act 2009 (the Act). It has been made by Lipa Pharmaceuticals Limited. The Agreement is a single enterprise agreement.

[2] The Employer has provided written undertakings. A copy of the undertakings is attached in Annexure A. I am satisfied that the undertakings will not cause financial detriment to any employee covered by the Agreement and that the undertakings will not result in substantial changes to the Agreement. The undertakings are taken to be a term of the agreement.

[3] Subject to the undertakings referred to above, I am satisfied that each of the requirements of ss.186, 187, 188 and 190 as are relevant to this application for approval have been met.

[4] The National Union of Workers being a bargaining representative for the Agreement, has given notice under s.183 of the Act that it wants the Agreement to cover it. In accordance with s.201(2) I note that the Agreement covers the organisation.

[5] The Agreement is approved and, in accordance with s.54 of the Act, will operate from 10 September 2019. The nominal expiry date of the Agreement is 10 September 2021.

COMMISSIONER

Printed by authority of the Commonwealth Government Printer

<AE505114  PR711979>

Annexure A